FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileWest Pharmaceutical Services, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WST
West Pharmaceutical Services, Inc. Stock AnalysisComprehensive stock analysis for West Pharmaceutical Services, Inc. (WST) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWST
WST
West Pharmaceutical Services, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WST
  1. Home
  2. Stocks
  3. West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

🇺🇸WST•NYSE

West Pharmaceutical Services, Inc.

🇺🇸WST•NYSE
Market cap
$29.10B
Sentiment

Your view on WST

Mkt Cap
$29.10B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About West Pharmaceutical Services, Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eric M. Green
Headquarters
530 Herman O. West Drive, Exton, PA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eric M. Green
Headquarters
530 Herman O. West Drive, Exton, PA, US
Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.

This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for West Pharmaceutical Services, Inc. from FRC's valuation model, read against the market price. WST last traded at $417.80, 46.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for West Pharmaceutical Services, Inc.. Starting points for West Pharmaceutical Services, Inc.: P/E 46.5, EPS $9.08, beta 1.14 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. paid $0.92 per share over the last year — a 0.2% yield at the current $417.80 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for West Pharmaceutical Services, Inc.. Trailing twelve-month EPS for West Pharmaceutical Services, Inc. stands at $9.08. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$413.38

average of 8 firms, last 12 months

 

$413.38

Low $315.00

Median $420.00

High $475.00

 

Analyst Ratings

Buy8 firms, last 12 months
  • Strong Buy0
  • Buy8
  • Hold0
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.29$2.36$9.49$10.36
Low estimate$2.25$2.21$8.99$9.51
High estimate$2.31$2.44$9.62$10.82
No. of analysts941010
Year-ago EPS$2.04$2.13$6.80—
Growth+12.3%+10.6%+39.6%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$825.22M$859.36M$3.42B$3.62B
Low estimate$821.74M$849.87M$3.38B$3.52B
High estimate$829.25M$873.96M$3.44B$3.71B
No. of analysts841212
Year-ago revenue$805.00M$844.90M$3.07B—
Growth+2.5%+1.7%+11.2%—
Recent analyst actions15 rating and price-target changes, latest Nov 2, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold WST17 companies · 8 funds
Compare WST with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ATRAptarGroup, Inc.Medical - Instruments & Supplies$9.1B
  • BLFSBioLife Solutions, Inc.Medical - Instruments & Supplies$1.9B
  • ICUIICU Medical, Inc.Medical - Instruments & Supplies$4.5B
  • SDMHFSartorius Stedim Biotech S.A.Medical - Instruments & Supplies$21.2B
  • SOAGYSartorius AGMedical - Instruments & Supplies$82.3B
  • STVNStevanato Group S.p.A.Medical - Instruments & Supplies$4.2B

More Medical - Instruments & Supplies companies

  • STAASTAAR Surgical CompanyNASDAQ$1.3B
  • STSSSharps Technology, Inc.NASDAQ$54M
  • STXSStereotaxis, Inc.AMEX$80M
  • SUVPFSartorius AGOTC$18.7B
  • SVSOSheerVision, Inc.OTC$2,551
  • TCGGYTecan Group AGOTC$2.3B
  • TCHBFTecan Group AGOTC$2.2B
  • TDVXFTobii Dynavox AB (publ)OTC$982M
  • TFXTeleflex IncorporatedNYSE$6.2B
  • TGLVYTop Glove Corporation Bhd.OTC$1.1B
  • TRJ.AXTrajan Group Holdings LimitedASX

ETFs holding West Pharmaceutical Services, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.04%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.04%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.28%
  • VUGVanguard Growth ETF$232.9B in assets0.11%
  • FMTMMarketDesk Focused U.S. Momentum ETF$268M in assets3.48%
  • BASGBrown Advisory Sustainable Growth ETF$507M in assets3.40%
  • KNGFT Cboe Vest S&P 500 Dividend Aristocrats Target Income ETF$3.5B in assets1.50%
  • NOBLProShares - S&P 500 Dividend Aristocrats ETF$12.1B in assets1.48%

Largest holders first, then the funds most concentrated in WST.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold West Pharmaceutical Services, Inc., and how their positions are changing. At a $29.10B market value, institutional positions materially move West Pharmaceutical Services, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by West Pharmaceutical Services, Inc. executives and directors. Shares of West Pharmaceutical Services, Inc. have traded between $187.43 and $348.90 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. is a $29.10B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming West Pharmaceutical Services, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for West Pharmaceutical Services, Inc.. Coverage tracks West Pharmaceutical Services, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of West Pharmaceutical Services, Inc.

WST Analysis
Good
Past5
Growth2
Health5
Profit3
Value1

News

Latest Market News